|
|
|
|
|
 |
Home |
 | |
 |
Calendar |
| |
|
Video |
| |
|
FAQs |
| |
|
Resources |
| |
| Upcoming Special Events | | |
|
|
|
The PSJMC CME Website is made possible through philanthropic support from the PSJ Foundation and our generous community. To learn more about funding resources and opportunities, please contact Angela Khurdajian 818-847-4669 or Angela.Khurdajian@providence.org. You may also visit our website by clicking here.
Providence Saint Joseph Medical Center is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.
Providence Saint Joseph Medical Center designates this enduring material for a maximum of
1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The CME Program at Providence Saint Joseph Center requires that this enduring material provide an assessment of the learner that measures achievement of purpose/objectives with minimum performance level required for credit. A post-test must be completed in order to receive
AMA PRA Category 1 Credit(s)™. for viewing videos on this site. A score of 3 out of 3 (100%) post-test questions answered correctly will be required to receive credit.
Each video is approximately 45 minutes in length, followed by a Q&A session.
A bibliography for each topic is available by contacting the CME Department at 818-847-3882.
To earn CME Credits, please read our FAQ's.
I have read the FAQ's and need to Register.
I'm registered and need to LOGIN.
|
|
Stress and Resilience in the Covid-19 Pandemic
TUESDAY, JUNE 30, 2020
12:15pm, Zoom Live Internet Activity
STRESS AND RESILIENCE DURING THE COVID-19 PANDEMIC
DALE G. LARSON, PH.D.
PROFESSOR, COUNSELING PSYCHOLOGY, SANTA CLARA UNIVERSITY
FELLOW, AMERICAN PSYCHOLOGICAL ASSOCIATION
Moderator:
Ira Byock, MD, Founder & Chief Medical Officer, Institute for Human Caring at
Providence St. Joseph Health
Planner/Faculty Disclosures:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. Larson states he has no financial relationships nor affiliations with any commercial company. Disclosures for members of the Medical Education Committee may be found on the CME website at
www.providencecme.org.
Click Here For Learning Objectives
Release Date: 09-4-20
Review Date: 09/23
Termination Date:
Providence Saint Joseph Medical Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|
|
6/30/2020
|
|
Dale
Larson,
PhD.
|
|
Presenter
|
|
Hope Conference Center
|
|
|
Complete Video Confirmation
In order to complete the evaluation, you must log in.
|
|
Gastrointestinal Manifestations of Covid-19
|
|
THURSDAY, JUNE 25, 2020
12:15pm, Zoom Live Internet Activity
GASTROINTESTINAL MANIFESTATIONS OF COVID-19
BRENNAN SPIEGEL, MD, MSHS, FACG, AGAF
PROFESSOR OF MEDICINE AND PUBLIC HEALTH,
DIRECTOR OF HEALTH SERVICES RESEARCH,
CEDARS-SINAI MEDICAL CENTER
EDITOR-IN-CHIEF, AM J OF GASTROENTEROLOGY
Moderator:
John Kasher, MD, Gastroenterology Section, Department of Medicine, PSJMC
Planner/Faculty Disclosures:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. Spiegel states he is on the Advisory Board and has received grant support from Takeda and Ironwood and is on the Advisory Board for Arena Pharma. It is our policy to review presentations ahead of time in order to resolve any potential conflicts of interest. No conflicts were identified in the review of today’s presentation. Disclosures for members of the Medical Education Committee may be found on the CME website at
www.providencecme.org.
Click Here For Learning Objectives
Release Date: 09-4-20
Review Date: 09/23
Termination Date:
Providence Saint Joseph Medical Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|
|
|
|
Vaccines Strategies to Prevent Covid-19 and Combination Immunotherapy with a Cancer Vaccine
|
|
Tuesday, June 23, 2020
12:15pm, Zoom live internet conference
VACCINE UPDATE: CORONAVIRUS AND ONCOLOGY TRIALS
BERNARD A. FOX, PHD
HARDER FAMILY CHAIR FOR CANCER RESEARCH
MEMBER AND CHIEF, LABORATORY OF MOLECULAR AND TUMOR IMMUNOLOGY,
PROVIDENCE PORTLAND MEDICAL CENTER
Planner/Moderator:
Ora Gordon, MD, MS; Regional Med. Dir., Center for Clinical Genetics & Genomics; Med. Dir., Integrative Medicine, Roy and Patricia Disney Family Cancer Center
Planner/Faculty Disclosures:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. Gordon states she has no financial arrangements nor affiliations with any commercial company to disclose. In managing a possible conflict of interest, Dr. Fox shares the following:
“As part of my conflict of Interest management program with Providence, I disclose all of my potential COI in my second slide – every time I speak. Typically I disclose anything within a 3 to 5 year time frame. In response to this form I limited the companies to the last 12 months.
UbiVac is a biotech spun-out of Providence. I am a Founder and the uncompensated (no salary) CEO of UbiVac. I am a 0.9FTE of Providence.
UbiVac is manufacturing the COVID-19 vaccine for the Providence sponsored Investigational New Drug application submitted to run the vaccine clinical trial.
UbiVac is also manufacturing the vaccine for a multicenter breast cancer vaccine trial that is being sponsored by BMS and led by a Providence breast oncologist.
I will talk about the COVID-19 vaccine trials as well as the Providence COVID-19 vaccine trial, cancer research, the monitoring of the immune response to cancer, monitoring trials and the clinical trials that are just starting.”
Disclosures for members of the Medical Education Committee may be found on the CME website at
www.providencecme.org.
Click Here For Learning Objectives
Release Date: 09-4-20
Review Date: 09/23
Termination Date:
Providence Saint Joseph Medical Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|
|
|
|
|
|
|
|
|
|
|